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The master regulator of metabolism and growth, mechanistic target of rapamycin 
complex 1 (mTORC1), is responsible for maintaining metabolic homeostasis by 
sensing nutrient and energy levels within the cell to promote or inhibit translation and 
autophagy accordingly. In the childhood neurodegenerative disorder Mucolipidosis type 
IV (MLIV), mTORC1 activity is decreased. The underlying mechanism for reduced 
mTORC1 signaling in MLIV is poorly understood. The gene encoding ganglioside-
induced differentiation associated protein 1 (GDAP1) is transcriptionally upregulated in 
MLIV. This project investigated the involvement of GDAP1 in MLIV disease pathology. 
Using the UAS/GAL4 system in an established MLIV Drosophila model, we knocked 
down expression of GDAP1. To determine the effect on mTORC1 activity, we 
measured phosphorylation levels of the mTORC1 downstream target S6 kinase (S6K) 
and quantified changes in synaptic growth at the larval neuromuscular junction (NMJ), 
which is a cell biological readout for mTORC1 activity. We found that knocking down 
GDAP1 expression can partially suppress the decreased phosphorylated S6K levels 
and rescue the reduced NMJ synaptic growth that occurs in MLIV Drosophila larvae. 
These results indicate that GDAP1 plays a role upstream of mTORC1 to affect 
signaling in MLIV cells. With this knowledge, we draw closer to understanding the 
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dysregulation of mTORC1 signaling that occurs in MLIV patients and gain insight into 
an incompletely understood mechanism for regulating metabolism.  
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1. Introduction 
 A cell’s ability to regulate its metabolism is essential to the fitness of an organism. 
The master regulator of metabolism and growth, mechanistic target of rapamycin 
complex 1 (mTORC1), coordinates various aspects of metabolism (Dibble and 
Manning, 2013; Laplante and Sabatini, 2012). Dysregulation of the mTORC1 pathway 
is implicated in the pathogenesis of many human diseases, such as cancers and 
metabolic disorders (Dazert and Hall, 2011; Menon and Manning, 2008; Laplante and 
Sabatini, 2012). One such metabolic disorder with mTORC1 signaling dysregulation is 
the neurodevelopmental disorder Mucolipidosis type IV (MLIV) (Wong et al., 2012). In 
addition to reduced mTORC1 activity, MLIV cells mishandle gangliosides (Bach et al., 
1975; Zeigler et al., 1992). Gangliosides regulate the expression of the ten ganglioside-
induced differentiation associated proteins (Liu et al., 1999). Preliminary data (not 
shown) has indicated that transcriptional upregulation of ganglioside-induced 
differentiation associated protein 1 (GDAP1) occurs in MLIV fibroblasts. While a 
connection between GDAP1 and mTORC1 activity has yet to be established, this 
preliminary result suggests that the two may be linked. Using the model organism 
Drosophila melanogaster, we investigate the involvement of GDAP1 in the metabolic 
regulation of MLIV cells. Probing the mechanistic underpinnings of this phenomenon 
will provide us with a more complete understanding of the metabolic regulation that is 
disrupted in MLIV. Ultimately, this insight could lead to innovative new therapies for this 
debilitating disease. 
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1.1 Mechanistic target of rapamycin complex 1 
Metabolism consists of anabolism and catabolism. Anabolism consists of processes 
that build up the cell, such as protein and lipid synthesis. Conversely, catabolism 
consists of processes that break down cellular components, such as autophagy. There 
must be a homeostasis of these processes for the cell to function optimally. To 
evaluate their resources, needs, and environmental situations, cells rely on the master 
regulator mTORC1. As a master regulator, mTORC1 receives cues from at least four 
major inputs (Brugarolas et al., 2004; Dibble and Manning, 2013; Gao et al., 2002; Inoki 
et al., 2002; Kimura et al., 2003), integrates the information, and communicates 
whether the cell is equipped for anabolism or whether it should engage in catabolism.  
The kinase complex mTORC1 inversely regulates protein translation and autophagy 
(Dibble and Manning, 2013). When active, mTORC1 phosphorylates downstream 
targets such as S6 kinase (S6K) and eukaryotic translation initiation factor 4E-binding 
protein 1 (4E-BP1) in a manner that encourages anabolism by facilitating protein 
translation (Zoncu et al., 2011a) (Figure 1, 2C). It also phosphorylates Wallenda (WND) 
(Fan et al., 1996), which is the first in a MAP kinase cascade that signals for 
neuromuscular junction (NMJ) synaptic growth through JNK (Fan et al., 1996; Wong et 
al., 2015) (Figure 1, 2C). Concomitantly, mTORC1 phosphorylates downstream targets 
such as unc-51 like autophagy activating kinase 1 (ULK1) and transcription factor EB 
(TFEB) to discourage catabolism by inhibiting autophagy and biogenesis of lysosomal 
components (Figure 1, 2C). This coordinated activity establishes a feedback loop within 
the cell to maintain homeostatic amino acid levels. As such, amino acid availability is 
one of the main inputs regulating mTORC1 activity. Other factors that contribute to 
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mTORC1 regulation include ATP availability, growth factors, and stress (Brugarolas et 
al., 2004; Dibble and Manning, 2013; Kimura et al., 2003) (Figure 1).  
Active mTORC1 is localized to the lysosomal membrane (Betz and Hall, 2013). Rag 
GTPase heterodimers and Ras homolog enriched in brain (Rheb) are key proteins in 
the localization and activation of mTORC1 on the lysosome. Rag GTPases respond to 
amino acid availability, and Rheb is indirectly modulated by ATP deprivation.  
Rag GTPases are responsible for recruiting mTORC1 to the lysosome from the 
cytoplasm by responding to amino acid levels (Sancak et al., 2008). GTPases are 
molecular switches that interchange between GDP-bound (inactive) and GTP-bound 
(active) states. Rag proteins heterodimerize on the surface of the lysosome (Sancak et 
al., 2008). Amino acids regulate the Rag-mTORC1 interaction by promoting the active 
GTP-bound state of one of the Rags in the dimer (Sancak et al., 2008). Information 
regarding amino acid availability is derived from amino acids in the lysosomal lumen. 
While the amino acid sensing mechanism is not fully elucidated, it has been shown that 
the trimeric Ragulator complex interacts with the Rag dimer to aid in localization of 
mTORC1 to the lysosomal membrane (Sancak et al., 2010). Additionally, the Ragulator 
engages in amino-acid dependent interactions with v-ATPases, which are proton 
pumps that regulate lysosomal acidity (Bar-Peled and Sabatini, 2014; Zoncu et al., 
2011b). In the presence of amino acids, the Rag heterodimer becomes active and 
promotes the translocation of mTORC1 to the lysosomal membrane (Figure 2A).  
The small G protein Rheb is located on the lysosome and is an allosteric activator 
required for mTORC1 activity (Stocker and Rheb, 2003). The tuberous sclerosis 1/ 
tuberous sclerosis 2 (TSC1/TSC2) complex deactivates Rheb by functioning as a 
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GTPase activating protein (GAP) (Inoki et al., 2003; Zhang et al., 2003) (Figure 2B). 
TSC1/TSC2 complex activity is positively regulated by 5′ AMP-activated protein kinase 
(AMPK) (Di Nardo et al., 2014). AMPK operates based on the ratio of AMP to ATP in 
the cell (Jeon, 2016). Through this energy sensing mechanism, AMPK inhibits 
mTORC1 when there are low energy levels. When there is more ATP than AMP 
present in a cell to indicate energy availability, mTORC1 is disinhibited (Jeon, 2016). In 
this manner, Rheb activates mTORC1 at the lysosome and AMPK informs mTORC1 of 
the energy status of the cell.  
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Figure 1. mTORC1 activators, inhibitors, and downstream targets 
Amino acids, energy (ATP), growth factors, and stress are the major sources of 
mTORC1 regulation. When active, mTORC1 activates anabolic processes and inhibits 
catabolic processes.  
Adapted from (Rabanal-Ruiz et al., 2017)  
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Figure 2. mTORC1 regulation and activity of mTORC1 
A) Rag GTPase dimers regulate mTORC1 localization to the lysosomal membrane. 
The left panel indicates cytoplasmic mTORC1 localization with an inactive Rag dimer. 
The right panel depicts Rag activation in the presence of luminal amino acids and 
localization of mTORC1 to the lysosomal membrane. 
B) AMPK regulates the activity of TSC1/TSC2, which modulates the activity of the 
mTORC1 allosteric activator Rheb. AMPK activity is regulated by the ratio of AMP to 
ATP in a cell. The left panel indicates that Rheb is deactivated by the AMP-driven 
activity of AMPK and the GAP activity of the TSC1/TSC2 complex. The right panel 
indicates that Rheb is active when AMPK activity is decreased due to more ATP in the 
cell.  
C) mTORC1 is active on the lysosomal membrane in the presence of an amino acid-
activated Rag dimer and the active allosteric mTORC1 activator Rheb. Activated 
mTORC1 phosphorylates S6K and WND, which initiates mRNA translation and NMJ 
synaptic growth, respectively. Activated mTORC1 phosphorylation of ULK1 inhibits the 
ability of ULK1 to initiate autophagy. 
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1.2 Mucolipidosis type IV 
MLIV is an autosomal recessive lysosomal storage disease (LSD) that results from 
a loss-of-function mutation in MCOLN1, the gene encoding the endolysosomal ion 
channel transient receptor potential mucolipin 1 (TRPML1) (Altarescu et al., 2002; Sun 
et al., 2000). MLIV was first recognized as a disease in 1974. It was described in a 
male infant of Ashkenazi Jewish ancestry (Berman et al., 1974). He presented with 
corneal opacity and abnormal accumulation of storage bodies in the liver, conjunctiva, 
and cultured skin fibroblasts (Berman et al., 1974). A majority of the affected individuals 
are of Ashkenazi Jewish ancestry, however MLIV is a pan-ethnic disorder (Amir et al., 
1987; Bargal et al., 2001). It occurs in 1 in 40,000 people, and the onset is early 
childhood (Altarescu et al., 2002; Amir et al., 1987; Bach, 2001). As the disease 
progresses, more features present themselves: severe psychomotor disability, impaired 
cognitive function, anemia, and achlorhydria (Altarescu et al., 2002; Amir et al., 1987; 
Wakabayashi et al., 2011).  
There is no effective treatment currently available for MLIV patients. Physical 
therapy can delay loss of muscle tone, but confinement to a wheelchair occurs by the 
end of the second decade of life (Bach, 2001; Wakabayashi et al., 2011). No strategies 
have been devised to counteract the cognitive impairment, although some patients 
have been reported to make small, continuous progress in language and cognitive 
functions (Amir et al., 1987). A promising therapeutic option would be to address the 
defects in cell signaling. Promoting healthy cellular communication may be able to 
circumvent some of the downstream effects caused by having nonfunctional TRPML1 
channels.  
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1.3 Transient receptor potential mucolipin 1 
TRPML1 is a cation channel that is predominantly localized to late endosomes and 
lysosomes (Manzoni et al., 2004; Wong et al., 2012). It is responsible for the release of 
calcium that ultimately enables the fusion of endosomes and autophagosomes to 
lysosomes (Wong et al., 2012) (Figure 3A). Endosomes and autophagosomes bring 
materials to lysosomes for degradation (Fader and Colombo, 2009). As the 
compartments draw close to each other, fusion machinery, known as soluble N-
ethylmaleimide sensitive factor attachment protein receptor (SNARES), tether the two 
vesicles together (Corona and Jackson, 2018). Then, TRPML1 channels release the 
calcium ions that enables the complete fusion of endosomes and autophagosomes to 
lysosomes through regulating components of the SNARE fusion machinery (Corona 
and Jackson, 2018) (Figure 3A). This fusion is a crucial step in delivering materials that 
need to be degraded to the lysosome. 
Cells that do not have functional TRPML1 channels have impaired lysosomal 
function. Having lost their ability to complete the fusion process, lysosomes lacking 
TRPML1 are caught in a “fusion-clamped” state with the opposing compartment and 
therefore, are hindered in their ability to degrade proteins (Figure 3B) (Wong et al., 
2012). This incomplete fusion results in insufficient degradation of waste materials, a 
consequence of which is fewer luminal amino acids available for detection by 
mTORC1. With a perceived lack of amino acid availability, mTORC1 ceases its 
suppression of autophagy. One of the main roles of the autophagy process is to raise 
amino acid levels by recycling current cellular components. In wild type animals, 
completion of autophagy leads to restored mTORC1 activity. However, in tissues from 
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the Drosophila MLIV model, autophagosomes are unable to fuse with lysosomes, 
resulting in an inability to complete the autophagy program and leaving the cell unable 
to restore mTORC1 activity (Wong et al., 2012). 
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Figure 3. TRPML1 function is impaired in Mucolipidosis type IV 
The fusion of an autophagosome (aut.) with a lysosome (lys.) requires two steps: 
tethering together of compartments by the SNARE machinery and release of 
calcium ions from TRPML1. The fusion process is depicted in wild type (A) and 
MLIV (B) cells. Due to the lack of TRPML1 in MLIV cells, autophagosomes and 
lysosomes are unable to complete the fusion process.  
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1.4 Ganglioside accumulation in MLIV 
Further findings from MLIV samples and models have revealed accumulations of 
mucopolysaccharides, phospholipids, and a 2-3-fold excess of GM3 and GD3 
gangliosides  (Bach et al., 1975, 1977, 1980; Bargal and Bach, 1989). Gangliosides are 
sialic acid-containing glycosphingolipids that primarily localize to the outer leaflets of 
the plasma membrane (Sonnino et al., 2007). They are integral components of the 
cholesterol-rich microdomains that participate in events such as cell-cell recognition 
and signal transduction (Lopez and Schnaar, 2009). The composition of cellular 
gangliosides changes from simple to more complex during the course of development 
due to the spatiotemporal regulation of ganglioside synthases (Ishii et al., 2007; 
Ngamukote et al., 2007; Vajn et al., 2013). However, in MLIV, there is an excess of the 
simple gangliosides GM3 and GD3. As development progresses, there is also 
regulation of the ten ganglioside-induced differentiation associated proteins (GDAPs). 
Preliminary data has shown that human retinal pigmented epithelial cells lacking 
functional TRPML1 have a transcriptional upregulation of GDAP1. Unsuccessful 
turnover of ganglioside species and the downstream results of this deviation, including 
GDAP1 upregulation, may have a role in the dysfunction that occurs in MLIV cells. 
Indeed, the mishandling of gangliosides occurring in MLIV adds a layer of complexity to 
our current understanding of the disease mechanism that merits investigation.  
1.5 Ganglioside-induced differentiation associated protein 1 
GDAP1 is an integral membrane protein of the outer mitochondrial membrane 
(OMM). It is a tail-anchored protein with one transmembrane domain (TMD) located at 
its carboxy terminal end (Wagner et al., 2009). The TMD and the basic amino acid 
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residues surrounding it facilitate GDAP1’s localization to the OMM (Niemann et al., 
2005; Wagner et al., 2009). At the OMM, GDAP1 contributes to mitochondrial health by 
functioning as a fission factor (Niemann et al., 2005; Wagner et al., 2009). The actions 
of fission and fusion illustrate mitochondrial dynamics. This dynamic process is 
important for the regulation of mitochondrial morphology and overall organelle health 
(Youle and van der Bliek, 2012). Dysregulation of mitochondrial dynamics is associated 
with neurodegenerative diseases (Bertholet et al., 2016; Pareyson et al., 2015). In fact, 
mutations in GDAP1 results in the neuropathy Charcot-Marie-Tooth disease (CMT). 
Niemann et al. showed that point mutations in GDAP1 occurring among CMT patients 
result in reduced mitochondrial fission capabilities (Niemann et al., 2005).  
According to bioinformatic analyses, GDAP1 shows structural similarity to the theta 
class glutathione S-transferase (GST) enzyme family (Huber et al., 2016; Shield et al., 
2006). It has an N-terminal and a C-terminal GST domain, both of which are located in 
the cytosol. Huber et al. (2016) were able to show in vitro that these domains do 
possess GST ability. Although, this activity was shown in a truncated construct of 
GDAP1 lacking the TMD and hydrophobic domain 1 (HD1). The HD1 is amphipathic 
and critical for mitochondrial fission activity (Huber et al., 2016; Wagner et al., 2009).  
1.6 Drosophila melanogaster as a model for investigating MLIV 
With well-characterized genetics, a broad range of genetic tools available, and 
easily recognizable developmental stages, Drosophila melanogaster is an excellent 
model organism for investigating interactions in the neurodevelopmental disease MLIV. 
Additionally, there is an established MLIV fly model (trpml1) and available assays for 
mTORC1 activity in flies (Venkatachalam et al., 2008; Wong et al., 2012, 2015). 
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The Drosophila larva neuromuscular system is a good genetic model for studying 
the excitatory synapses of the mammalian central nervous system (Menon et al., 
2013). Additionally, synaptic growth at the neuromuscular junction (NMJ) can be used 
as a cell biological read out for mTORC1 activity (Wong et al., 2015). NMJ synaptic 
growth can be quantified by counting the number of boutons present at an NMJ. 
Boutons are the round enlargements of an axon that form a synapse with another cell. 
Drosophila have three main types of boutons. Type 1 boutons are glutamatergic while 
types 2 and 3 are modulatory and use other neurotransmitters (Menon et al., 2013). Of 
the type 1 boutons, there are 1b and 1s boutons, for big and small respectively. The 
size classification is based on the amount of subsynaptic reticulum (SSR) present. At 
the NMJ, SSR is the post-synaptic muscle membrane that surrounds the pre-synaptic 
bouton (Menon et al., 2013). It consists of scaffolding proteins, neurotransmitter 
receptors, and post-synaptic signaling complexes. One of the scaffolding proteins of 
the SSR is called disc large (DLG) (Chen and Featherstone, 2005).  
During neural development, boutons are frequently being generated and eliminated 
(Menon et al., 2013). Therefore, the ability to distinguish a functional bouton from a 
nonfunctional bouton is essential. Functional boutons are recognized by participation of 
both pre-synaptic and post-synaptic membranes in synapse formation. A reliable post-
synaptic marker is the scaffolding protein DLG. An accepted pre-synaptic marker is 
horse radish peroxidase (HRP), which stains axons (Nässel, 1983; Romero et al., 
1999). Therefore, functional boutons can be identified by containing both the pre-
synaptic HRP signal and the post-synaptic DLG signal. By counting functional boutons 
according to these parameters, we can approximate the activity level of mTORC1. 
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Another way to measure mTORC1 activity in Drosophila is to assay the 
phosphorylation status of the mTORC1 downstream target S6K in larvae fat body 
tissue. The Drosophila fat body is a highly metabolic organ. It is the main site for 
energy storage and utilization (Arrese and Soulages, 2010; Law and Wells, 1989). In 
these capacities, it is similar in function to the human liver and adipose tissue. It 
coordinates energy utilization and biosynthesis to meet the metabolic needs of the 
organism (Arrese and Soulages, 2010). Being centrally located and bathed in 
hemolymph, the fat body is ideally positioned to integrate signals from other organs 
(Arrese and Soulages, 2010). With such an insight into the metabolic health of the 
organism, the fat body is well suited for assaying mTORC1 activity.   
1.7 Project summary and hypothesis 
With the knowledge that mTORC1 activity is essential to the well-being of cells, 
elucidating its regulation in disease states can give us insight into potential therapeutic 
targets and provide a more complete understanding of metabolism and its regulation. 
The aim of this project was to determine if GDAP1 plays a role in the dysregulated 
mTORC1 signaling present in cells lacking TRPML. We hypothesized that GDAP1 
induction affects the cellular and neurological defects prevalent in MLIV patients. To 
investigate the relationship between GDAP1 levels and mTORC1 activity in MLIV, we 
knocked down expression of GDAP1 in the Drosophila model of MLIV (trpml1), and 
determined mTORC1 activity by measuring phosphorylation status of the downstream 
target S6K and quantifying synaptic growth at neuromuscular junctions. Understanding 
the involvement of GDAP1 in this disease process brings us one step closer to 
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comprehending the molecular events that occur in MLIV and draws us to a more 
complete understanding of metabolic regulation as a whole. 
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2. Materials and Methods 
2.1 Drosophila strains 
The Drosophila strains acquired for this study were: w[1118]; P{GD10713}v21624 (UAS-
GDAP1RNAi) (Vienna Drosophila Resource Center) (Dietzl et al., 2007), elav-GAL4 
(pan-neuronal expression) (Lin and Goodman, 1994) and cg-GAL4 (hemocyte and fat 
body expression) (Hennig et al., 2006). The UAS-GDAP1RNAi line was used as the 
control for these studies. The trpml1 related strains used were: trpml1/TM6β 
(Venkatachalam et al., 2008), elav-GAL4;; trpml1/TM6β, cg-GAL4; trpml1/TM6β, and 
UAS-GDAP1RNAi; trpml1/TM6β. The experimental lines were generated by crossing 
elav-GAL4 or cg-GAL4 or UAS-GDAP1RNAi with trpml1/TM6β or UAS-GDAP1RNAi 
accordingly. 
2.2 Drosophila husbandry 
All fly stocks were raised at room temperature (~22 °C) in 25 mm vials. Ingredients of 
the fly food were as previously described (Wong et al., 2012). 
Each fly cross consisted of 5 males and 5 virgin females. These crosses were 
maintained at 25 °C under 12-hour light-dark cycle. After the first 2-3 days, the adults 
were flipped into new vials with fresh food, and the old vials were discarded. Larvae 
from this second set of vials were used for experiments.  
2.3 NMJ dissections 
2.3.1 Preparing fillets 
Wandering third instar larvae were selected from vials and placed in dissection dishes 
containing Sylgard (Dow Corning) where they were bathed in cold 1X phosphate 
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buffered saline (PBS) solution. Larvae were pinned at the anterior and posterior ends. 
An incision was made on the dorsal surface of the body wall to expose the internal 
organs. The internal organs were removed, leaving only the brain inside. Four to six 
fillets were pinned flat on the Sylgard surface and fixed in 4% paraformaldehyde 
(Electron Microscopy Sciences) for 30 minutes. The fillets were then washed in 0.1% 
Triton X in PBS for ~15 minutes. 
2.3.2 Immunohistochemistry for bouton visualization 
The primary antibody solution consisted of 1:100 anti-discs large-c (α-DLG) (DSHB) 
and 5% NDS in 200 µl 0.1% Triton X in PBS. Fillets were incubated in the primary 
antibody solution overnight at 4 °C. They were washed in 0.1% Triton X in PBS ~20 
minutes, and then incubated with secondary antibody solution for 2 hours on a rocker 
at 60 rpm. Secondary antibody solution contained: 1:200 anti-horse radish peroxidase 
(α-HRP) (Jackson), 1:400 AlexaFluor 568nm goat anti-mouse IgG (Life Technologies), 
and 5% NDS in 200 µl 0.1% Triton X in PBS. Then the fillets were washed for another 
~15 minutes in 0.1% Triton X in PBS. The fillets were then mounted on a glass slide 
using Vectashield mounting medium with DAPI (Vector Laboratories). 
2.3.3 Confocal imaging of NMJs 
Confocal images of the NMJs were obtained using a Nikon A1 Confocal Laser 
Microscope System. Using the 60X oil-immersion objective lens, a z-stack of the NMJ 
in segment A3 at muscle 6/7 located on either side of the midline of each animal was 
obtained using channel series line 1-> 4.   
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2.3.4 Parameters for counting boutons 
NMJ synaptic growth was quantified by counting the number of type 1 boutons present 
at each NMJ. Boutons were counted as functional if they were positive for both the pre-
synaptic HRP signal and the post-synaptic DLG signal. 
2.3.5 Analysis of bouton numbers 
GraphPad Prism 6 software was used to analyze the NMJ synaptic growth data. 
Welch’s t test and the Mann Whitney test were used to detect differences in conditions. 
2.4 Fat body dissections 
2.4.1 Larvae starvation procedure 
Third instar larvae were removed from their food and placed in a vial containing cotton 
wet with a 1% sucrose solution. These vials were incubated at 25 °C for either 4 hours 
or 15 hours before being dissected.  
2.4.2 Dissecting out fat bodies 
Female wandering third instar larvae were selected from vials, placed in dissection 
dishes containing Sylgard (Dow Corning), and bathed in cold Schneider’s Insect 
Medium (Sigma Life Science). Larvae were pinned at their anterior and posterior ends. 
An incision was made on the dorsal surface of the body wall to expose the internal 
organs. The fat bodies were separated from the other organs and removed from the 
solution. They were placed in a depression well slide containing 45 µl 2X Laemmli 
sample buffer (Bio-Rad) with 5% β-mercaptoethanol. After pipetting briefly, the samples 
were heated at 100 °C for 5 minutes. Fat bodies were dissected out of animals one at a 
time, but the fat bodies from two animals went into each sample. 
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2.4.3 Western blot procedures 
Fat body samples were heated at 100 °C for 2 minutes, briefly vortexed, and 
centrifuged for 30 seconds at 15,000 rpm. The samples were then loaded into a 4%-
20% gradient gel (Bio-Rad) and run at 60 V for 2.5 hours. Proteins were transferred 
onto a nitrocellulose membrane at 120 mA for 3 hours at 4 °C. Before being probed 
with antibodies, the membrane underwent blocking in Odyssey Blocking Buffer for 40 
minutes while being rocked at 60 rpm. The primary antibodies used to probe the 
membrane were as follows: 1:1000 rabbit P-Drosophila p70 S6 Kinase (Cell Signaling) 
and 1:1000 mouse anti-α-tubulin (DSHB). The secondary antibodies used were 
1:15,000 IRDye 680LT goat anti-rabbit and 1:20,000 IRDye 800CW goat anti-mouse, 
both from LI-COR. These proteins were visualized using the LI-COR Odyssey infrared 
imager and Odyssey Program. 
2.4.4 Analysis of pS6K quantification 
Western blots were quantified using ImageJ software. Analysis of Western blot 
quantifications was done using unpaired t tests in GraphPad Prism 6 software. 
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3. Results 
3.1 GDAP1 knockdown enables rescue of NMJ synaptic growth in trpml1 mutant 
larvae 
Neuromuscular junction (NMJ) synaptic growth is regulated by mTORC1 activity 
(Wong et al., 2015). In order to determine the effect of GDAP1 on NMJ synaptic 
growth, we used a neuronal driver in the UAS/GAL4 system to express a UAS-
GDAP1RNAi construct in the neurons of third instar larvae from wild type and trpml1 
mutant backgrounds (Figure 4A). Using immunohistochemistry, we visualized the NMJ 
by staining with HRP, a pre-synaptic marker in nervous tissue, and DLG, a post-
synaptic marker in muscle tissue. Confocal images of the NMJs at muscles 6/7 of the 
A3 segment of these preparations were used for quantification of NMJ synaptic growth 
(Figure 4B). 
At the molecular level, Figure 4C depicts the sequence of events that ordinarily 
occur to result in NMJ synaptic growth. In wild type larvae, there is no significant 
difference in the number of boutons in larvae expressing the UAS-GDAP1RNAi construct 
in their neurons compared with control larvae that do not express the UAS-GDAP1RNAi 
construct in their neurons (p = 0.4452) (Figure 4D-E). This indicates that knocking 
down GDAP1 alone does not affect NMJ synaptic growth. 
In homozygous trpml1 larvae, there was a 15% decrease in the number of boutons 
present at the NMJ compared to trpml1 heterozygous larvae (p = 0.0084). This deficit 
was rescued by expressing the UAS-GDAP1RNAi construct in the neurons of 
homozygous trpml1 larvae (p = 0.0095) (Figure 4D-E). This recovery indicates that 
knocking down expression of GDAP1 in neurons enables wild type levels of NMJ 
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synaptic growth in trpml1 homozygous larvae, suggesting that GDAP1 plays a role 
upstream of NMJ synaptic growth.  
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Figure 4. GDAP1 knockdown enables rescue of NMJ synaptic growth in trpml1 
mutant larvae 
A) Schematic depicting the UAS/GAL4 system used to knock down GDAP1 expression 
in neuronal tissue.   
Adapted from (Prüßing et al., 2013) 
B) Graphic representation of a larva fillet. The red box indicates segment A3 muscle 
6/7 of a larva. On either side of the midline, this is the location of the NMJs imaged for 
all NMJ synaptic growth quantification. The ventral nerve cord refers to the lower 
portion of the brain from where motor neuron axons emanate. 
Adapted from (Inoshita et al., 2017) 
C) The relevant molecular events that occur to yield NMJ synaptic growth. TRPML1 
releases calcium ions to aid in the fusion of an autophagosome and lysosome. The 
lysosome degrades proteins resulting in luminal amino acids, which recruit mTORC1 to 
the lysosomal surface. mTORC1 phosphorylates the MAP kinase cascade that 
includes JNK. JNK activity stimulates NMJ synaptic growth.  
D) Representative confocal images of NMJs in larvae of different genotypes. Magenta 
stain indicates the post-synaptic signal, DLG. Green stain indicates the pre-synaptic 
signal, HRP. 
E) Quantification of bouton numbers in all NMJs visualized. **p<0.01 
The number of NMJ images quantified for each genotype are as follows from left to 
right: n = 16, 28, 40, 13, 34 
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3.2 GDAP1 knockdown in trpml1 mutant larvae enables recovery of S6K 
phosphorylation levels 
To evaluate mTORC1 signaling biochemically, we expressed the UAS-GDAP1RNAi 
construct in the fat body tissue of wild type and trpml1 homozygous larvae and assayed 
for phosphorylation of S6K, a substrate of mTORC1 (Figure 5A). Figure 5B depicts the 
molecular events that occur to result in S6K phosphorylation. It has previously been 
shown that trpml1 homozygous larvae have reduced mTORC1 signaling compared to 
wild type larvae (Wong et al., 2012). My results are consistent with this finding. The 
trpml1 homozygous larvae have decreased pS6K levels in comparison with those of 
wild type larvae (p = 0.0249) (Figure 5C). This decrease in pS6K level is then rescued 
by expressing the UAS-GDAP1RNAi construct in fat body tissue of trpml1 homozygous 
larvae (p = 0.0402). The rescued pS6K level indicates that knocking down expression 
of GDAP1 in fat body tissue contributes to restoration of mTORC1 signaling in trpml1 
homozygous larvae. 
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Figure 5. GDAP1 knockdown in trpml1 mutant larvae enables recovery of S6K 
phosphorylation levels  
A) Schematic depicting the UAS/GAL4 system used to knock down GDAP1 expression 
in fat body tissue.   
Adapted from (Prüßing et al., 2013) 
B) The relevant molecular events that occur to yield S6K phosphorylation. TRPML1 
releases calcium ions to aid in the fusion of an autophagosome and a lysosome. The 
lysosome degrades proteins resulting in luminal amino acids, which recruits mTORC1 
to the lysosomal surface. mTORC1 phosphorylates S6K. 
C) Quantification of pS6K signal from fat body tissue normalized to tubulin. *p<0.05 
The number of fat body samples quantified for each genotype are n = 8, 7,4 for control, 
trpml1, and GDAP1 knockdown in trpml1, respectively. 
D) Quantification of pS6K signal at different time points in a starvation time course. 
pS6K signal is normalized to tubulin. *p<0.05 
The number of fat body samples quantified for each genotype at the 4-hour starvation 
time point are n = 8, 7, 6 for control, trpml1, and GDAP1 knockdown in trpml1, 
respectively. 
The number of fat body samples quantified for each genotype at the 15-hour starvation 
time point are n = 8, 6, 3 for control, trpml1, and GDAP1 knockdown in trpml1, 
respectively. 
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3.3 Knockdown of GDAP1 aids in recovery of S6K phosphorylation level in 
response to starvation in trpml1 mutant larvae 
Another way to prevent mTORC1 suppression of autophagy is through starvation, 
which removes the dietary intake of mTORC1-activating amino acids. Through use of a 
starvation time course, we can evaluate the recovery process of S6K phosphorylation 
level in response to a stressor. During the starvation time course, the larvae had 
access to sucrose as a source for ATP production. This was to ensure that the 
mTORC1 input being affected was amino acid availability.  
There is a divergent response in mTORC1 activity during starvation of wild type and 
trpml1 larvae. The larvae from the wild type background show a decrease in pS6K 
levels at 4 hours of starvation followed by a clear recovery of pS6K levels at 15 hours 
of starvation (Figure 5D). This indicates that the animal registered the depletion of 
luminal amino acids and initiated a method to restore the amino acid deficit, namely 
autophagy. In this manner, it was able to successfully replenish luminal amino acid 
levels to restore mTORC1 activity. The larvae from the trpml1 mutant background 
exhibit the opposite response. The trpml1 pS6K levels decrease at 4 hours of starvation 
and do not recover over the starvation time course. At 15 hours of starvation, there is a 
50% decrease in pS6K level from wild type to trpml1 mutant larvae (p = 0.0018). This 
suggests that the method to replenish luminal amino acids is unable to function in 
trpml1 mutant larvae. However, the trpml1 larvae that express the UAS-GDAP1RNAi 
construct show pS6K levels that are 25% greater than those of trpml1 larvae not 
expressing the construct (p = 0.0398). This indicates that knocking down expression of 
GDAP1 aids in the recovery of mTORC1 activity in cells that lack functional TRPML.   
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4. Discussion 
mTORC1 plays a major role in the regulation of metabolism. Understanding how it 
is affected in disease states can give us insight into the complexity of metabolic 
regulation. Through this investigation, I have shown that knockdown of GDAP1 enables 
rescue of NMJ synaptic growth and recovery of pS6K levels in trpml1 mutant larvae, a 
cell biological and biochemical readout for mTORC1 activity, respectively. Additionally, 
I have shown that knockdown of GDAP1 in trpml1 mutant larvae aids in the recovery of 
pS6K levels in response to starvation. These results support the hypothesis that 
GDAP1 impacts mTORC1 activity, therefore identifying a role for GDAP1 upstream of 
the master kinase. This conclusion implies that the mechanism through which GDAP1 
is affecting mTORC1 activity is through one of the four main mTORC1 inputs: ATP 
availability, amino acid availability, growth factors, or stress.  
GDAP1 could be regulating mTORC1 activity through manipulating ATP availability.  
ATP is generated predominantly through oxidative phosphorylation in the mitochondria. 
Mitochondrial dynamics play an important role in regulating energy production (Youle 
and van der Bliek, 2012; Zemirli et al., 2018; Westermann, 2012). One role of fission is 
to segregate dysfunctional portions of mitochondria to be degraded eventually by 
mitophagy (Westermann, 2012; Youle and van der Bliek, 2012). This process reduces 
the amount of ATP that can be synthesized by way of eliminating some of the ATP 
synthesis machinery. With this understanding, we can hypothesize that by inhibiting 
fission, we can protect mitochondria from mitophagy.  
Additionally, fusion can mitigate the loss of this machinery by causing 
complementation of dysfunctional mitochondria with healthy mitochondria, thereby 
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prolonging mitochondrial function by revitalizing the components (Westermann, 2012; 
Youle and van der Bliek, 2012). In this way, fusion can increase oxidative 
phosphorylation and ATP synthesis. Fusion during cellular stress enables the cell to 
meet the increasing energy demand. In this regard, a highly connected mitochondrial 
network correlates with increased ATP production (Westermann, 2012). It has been 
shown that elongated mitochondria have been spared from autophagy (Gomes et al., 
2011; Rambold et al., 2011). The added connectivity of these mitochondrial networks is 
associated with oxidative phosphorylation efficiency. Additionally, there is some 
evidence to suggest that mitochondrial elongation is facilitated by knocking down 
GDAP1 expression (Niemann et al., 2005). In this manner, knocking down expression 
of the fission protein GDAP1 may cause an increase in ATP production. Increased ATP 
levels would garner less AMPK suppression of mTORC1 thereby enabling increased 
mTORC1 activity. In fact, targeting mitochondrial fission has previously been suggested 
to help with mitochondrial dysfunction occurring in neurodegenerative diseases (Reddy, 
2014).  
To investigate GDAP1 involvement in altering the ATP levels in cells lacking 
TRPML1, we could block fission pharmacologically and assay for AMPK activity. This 
would help us determine if it is the reduced mitochondrial fission capacity of the GDAP1 
knockdown cells that affect mTORC1 activity. 
Alternatively, knockdown of GDAP1 could be increasing mTORC1 activity through 
increasing amino acid availability. Loss of TRPML1 function affects amino acid 
availability. This is known because ectopic addition of amino acids suppresses the 
phenotypes caused by loss of TRPML1 function (Wong et al., 2012). Mitochondria have 
31 
 
the capacity to generate amino acids, such as glutamine. Being that mTORC1 is 
sensitive to glutamine (Jewell et al., 2015), increasing generation of glutamine in the 
mitochondria could aid in recovery of mTORC1 activity.  
The citric acid cycle intermediate α-ketoglutarate can be transformed into glutamine 
in two reactions. Glutamate dehydrogenase (GDH) catalyzes the reaction from 
glutamate to α-ketoglutarate within the mitochondria (Prough et al., 1973). GDH is 
negatively regulated by ATP, meaning that high ATP levels would cause the reaction to 
favor glutamate generation (Prough et al., 1973). GDH is positively regulated by ADP, 
indicating that low energy levels would drive the reaction toward α-ketoglutarate 
generation (Prough et al., 1973). Glutamate can generate glutamine through a reaction 
catalyzed by glutamine synthase (Frigerio et al., 2008). In this model, as ATP levels 
increase from reduced fission, GDH is inhibited and the α-ketoglutarate in the cell is 
converted into glutamate which can then be converted into glutamine. Glutamine in turn 
can provide the amino acids to increase mTORC1 activity. In this fashion, mitochondrial 
activity can increase the amino acid availability of the cell.  
In sum, this study has revealed a role for the fission protein GDAP1 in the regulation 
of mTORC1 activity in a Drosophila model of Mucolipidosis type IV. Figure 6 depicts 
the cross talk between lysosomes and mitochondria that our findings suggest occur to 
impact mTORC1 activity. Regardless of the mechanism of action, the results of this 
study support our hypothesis and suggest that the upregulation of GDAP1 known to 
occur in MLIV patients contributes to the decreased mTORC1 activity in cells that lack 
functional TRPML1. As this line of research continues, we may find GDAP1 to be a 
suitable target for MLIV therapeutics. As it stands, the research contained in this study 
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supplies a valuable piece of knowledge to our understanding of MLIV and metabolic 
regulation as a whole.  
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Figure 6. Cross talk between lysosomes and mitochondria impacts mTORC1 
activity 
Lysosomal function is known to be required for mTORC1 activation and processing 
gangliosides. Gangliosides regulate the transcription of GDAP1, a gene that encodes a 
mitochondrial protein. Our findings suggest that the upregulation of GDAP1 known to 
occur in MLIV patients acts to negatively regulate mTORC1 activity in cells with 
lysosomal dysfunction. 
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